Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Depisch

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trialG V Kornek, B Schuell, F Laengle, et al.
Breast Cancer Research and Treatment|December 8, 2000
Treatment of advanced, refractory breast cancer with alternating docetaxel and epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factorW Kwasny, G Kornek, K Haider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancerW Scheithauer, G V Kornek, M Raderer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapyW Scheithauer, G V Kornek, B Schuell, et al.
Infection|April 30, 1998
Single-dose cefodizime as infection prophylaxis in abdominal surgery: a prospective multicenter studyF Thalhammer, F Traunmüller, H J Böhming, et al.
Investigational New Drugs|May 1, 1990
Pirarubicin (4'-o-tetrahydropyranil-adriamycin) for treatment of advanced breast cancer. A Clinical Phase II studyW Scheithauer, H Samonigg, D Depisch, et al.
Cancer|April 3, 2001
Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma: results of a Phase I-II trialW Scheithauer, G V Kornek, H Ulrich-Pur, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 13, 2002
Long-term follow-up of surgically treated gallbladder cancer patientsH Puhalla, T Wild, E Bareck, et al.
Annals of the New York Academy of Sciences|August 12, 1993
Adjuvant vaccination in colorectal carcinomaE Ulsperger, H Rainer, G Locker, et al.
Cancer|March 15, 1994
Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancerW Scheithauer, D Depisch, G Kornek, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trialG V Kornek, B Schuell, F Laengle, et al.
Breast Cancer Research and Treatment|December 8, 2000
Treatment of advanced, refractory breast cancer with alternating docetaxel and epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factorW Kwasny, G Kornek, K Haider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancerW Scheithauer, G V Kornek, M Raderer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapyW Scheithauer, G V Kornek, B Schuell, et al.
Infection|April 30, 1998
Single-dose cefodizime as infection prophylaxis in abdominal surgery: a prospective multicenter studyF Thalhammer, F Traunmüller, H J Böhming, et al.
Investigational New Drugs|May 1, 1990
Pirarubicin (4'-o-tetrahydropyranil-adriamycin) for treatment of advanced breast cancer. A Clinical Phase II studyW Scheithauer, H Samonigg, D Depisch, et al.
Cancer|April 3, 2001
Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma: results of a Phase I-II trialW Scheithauer, G V Kornek, H Ulrich-Pur, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 13, 2002
Long-term follow-up of surgically treated gallbladder cancer patientsH Puhalla, T Wild, E Bareck, et al.
Annals of the New York Academy of Sciences|August 12, 1993
Adjuvant vaccination in colorectal carcinomaE Ulsperger, H Rainer, G Locker, et al.
Cancer|March 15, 1994
Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancerW Scheithauer, D Depisch, G Kornek, et al.
Pageof 8